Details for Patent: 8,143,239
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,143,239 protect, and when does it expire?
Patent 8,143,239 protects SYMBICORT and is included in one NDA.
Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-five patent family members in twenty-seven countries.
Summary for Patent: 8,143,239
Title: | Composition for inhalation |
Abstract: | The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000. |
Inventor(s): | Govind; Nayna (Leicestershire, GB), Marlow; Maria (Leicestershire, GB) |
Assignee: | AstraZeneca AB (Sodertalje, SE) |
Application Number: | 12/790,196 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,143,239 |
Patent Claim Types: see list of patent claims | Composition; Compound; Delivery; Use; |
Drugs Protected by US Patent 8,143,239
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-002 | Jul 21, 2006 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,143,239
International Family Members for US Patent 8,143,239
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 423552 | See Plans and Pricing | |||
Austria | 463241 | See Plans and Pricing | |||
Australia | 2003206289 | See Plans and Pricing | |||
Brazil | 0307193 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |